BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pillai A, Howell KR, Ahmed AO, Weinberg D, Allen KM, Bruggemann J, Lenroot R, Liu D, Galletly C, Weickert CS, Weickert TW. Association of serum VEGF levels with prefrontal cortex volume in schizophrenia. Mol Psychiatry 2016;21:686-92. [PMID: 26169975 DOI: 10.1038/mp.2015.96] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 7.1] [Reference Citation Analysis]
Number Citing Articles
1 Casas BS, Arancibia-altamirano D, Acevedo-la Rosa F, Garrido-jara D, Maksaev V, Pérez-monje D, Palma V. It takes two to tango: Widening our understanding of the onset of schizophrenia from a neuro-angiogenic perspective. Front Cell Dev Biol 2022;10:946706. [DOI: 10.3389/fcell.2022.946706] [Reference Citation Analysis]
2 Brown JS. Treatment of cancer with antipsychotic medications: Pushing the boundaries of schizophrenia and cancer. Neurosci Biobehav Rev 2022;141:104809. [PMID: 35970416 DOI: 10.1016/j.neubiorev.2022.104809] [Reference Citation Analysis]
3 Saoud H, Aflouk Y, Ben Afia A, Gaha L, Bel Hadj Jrad B. Association of VEGF-A and KDR polymorphisms with the development of schizophrenia. Human Immunology 2022. [DOI: 10.1016/j.humimm.2022.04.003] [Reference Citation Analysis]
4 Morozova A, Zorkina Y, Abramova O, Pavlova O, Pavlov K, Soloveva K, Volkova M, Alekseeva P, Andryshchenko A, Kostyuk G, Gurina O, Chekhonin V. Neurobiological Highlights of Cognitive Impairment in Psychiatric Disorders. Int J Mol Sci 2022;23:1217. [PMID: 35163141 DOI: 10.3390/ijms23031217] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
5 Liu Y, Chen J, Huang L, Yan S, Bian Q, Yang F. Relationships Among Retinal Nerve Fiber Layer Thickness, Vascular Endothelial Growth Factor, and Cognitive Impairment in Patients with Schizophrenia. Neuropsychiatr Dis Treat 2021;17:3597-606. [PMID: 34916796 DOI: 10.2147/NDT.S336077] [Reference Citation Analysis]
6 Hoang D, Xu Y, Lutz O, Bannai D, Zeng V, Bishop JR, Keshavan M, Lizano P. Inflammatory Subtypes in Antipsychotic-Naïve First-Episode Schizophrenia are Associated with Altered Brain Morphology and Topological Organization. Brain Behav Immun 2021;100:297-308. [PMID: 34875344 DOI: 10.1016/j.bbi.2021.11.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
7 Chalkiadaki K, Statoulla E, Markou M, Bellou S, Bagli E, Fotsis T, Murphy C, Gkogkas CG. Translational control in neurovascular brain development. R Soc Open Sci 2021;8:211088. [PMID: 34659781 DOI: 10.1098/rsos.211088] [Reference Citation Analysis]
8 Bairwa SC, Shaw CA, Kuo M, Yoo J, Tomljenovic L, Eidi H. Cytokines profile in neonatal and adult wild-type mice post-injection of U. S. pediatric vaccination schedule. Brain Behav Immun Health 2021;15:100267. [PMID: 34589773 DOI: 10.1016/j.bbih.2021.100267] [Reference Citation Analysis]
9 Rampino A, Annese T, Torretta S, Tamma R, Maria Falcone R, Ribatti D. Involvement of vascular endothelial growth factor in schizophrenia. Neurosci Lett 2021;760:136093. [PMID: 34216717 DOI: 10.1016/j.neulet.2021.136093] [Reference Citation Analysis]
10 Yoneda N, Yoneda S, Tsuda S, Ito M, Shiozaki A, Niimi H, Yoshida T, Nakashima A, Saito S. Pre-eclampsia Complicated With Maternal Renal Dysfunction Is Associated With Poor Neurological Development at 3 Years Old in Children Born Before 34 Weeks of Gestation. Front Pediatr 2021;9:624323. [PMID: 33996679 DOI: 10.3389/fped.2021.624323] [Reference Citation Analysis]
11 Valiuliene G, Valiulis V, Dapsys K, Vitkeviciene A, Gerulskis G, Navakauskiene R, Germanavicius A. Brain stimulation effects on serum BDNF, VEGF, and TNFα in treatment-resistant psychiatric disorders. Eur J Neurosci 2021;53:3791-802. [PMID: 33861484 DOI: 10.1111/ejn.15232] [Reference Citation Analysis]
12 Laskaris L, Mancuso S, Shannon Weickert C, Zalesky A, Chana G, Wannan C, Bousman C, Baune BT, McGorry P, Pantelis C, Cropley VL. Brain morphology is differentially impacted by peripheral cytokines in schizophrenia-spectrum disorder. Brain Behav Immun 2021;95:299-309. [PMID: 33838248 DOI: 10.1016/j.bbi.2021.04.002] [Reference Citation Analysis]
13 Ushakov VL, Malashenkova IK, Kostyuk GP, Zakharova NV, Krynskiy SA, Kartashov SI, Ogurtsov DP, Bravve LV, Kaydan MA, Hailov NA, Chekulaeva EI, Didkovsky NA. [The relationship between inflammation, cognitive disorders and neuroimaging data in schizophrenia]. Zh Nevrol Psikhiatr Im S S Korsakova 2020;120:70-8. [PMID: 33340301 DOI: 10.17116/jnevro202012011170] [Reference Citation Analysis]
14 Penna E, Mangum JM, Shepherd H, Martínez-Cerdeño V, Noctor SC. Development of the Neuro-Immune-Vascular Plexus in the Ventricular Zone of the Prenatal Rat Neocortex. Cereb Cortex 2021;31:2139-55. [PMID: 33279961 DOI: 10.1093/cercor/bhaa351] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Lizano P, Lutz O, Xu Y, Rubin LH, Paskowitz L, Lee AM, Eum S, Keedy SK, Hill SK, Reilly JL, Wu B, Tamminga CA, Clementz BA, Pearlson GD, Gershon ES, Keshavan MS, Sweeney JA, Bishop JR. Multivariate relationships between peripheral inflammatory marker subtypes and cognitive and brain structural measures in psychosis. Mol Psychiatry 2021;26:3430-43. [PMID: 33060818 DOI: 10.1038/s41380-020-00914-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
16 Pu J, Liu Y, Gui S, Tian L, Xu S, Song X, Zhong X, Chen Y, Chen X, Yu Y, Liu L, Zhang H, Wang H, Zhou C, Zhao L, Xie P. Vascular endothelial growth factor in major depressive disorder, schizophrenia, and bipolar disorder: A network meta-analysis. Psychiatry Res 2020;292:113319. [PMID: 32717712 DOI: 10.1016/j.psychres.2020.113319] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
17 Ornoy A, Becker M, Weinstein-Fudim L, Ergaz Z. S-Adenosine Methionine (SAMe) and Valproic Acid (VPA) as Epigenetic Modulators: Special Emphasis on their Interactions Affecting Nervous Tissue during Pregnancy. Int J Mol Sci 2020;21:E3721. [PMID: 32466248 DOI: 10.3390/ijms21103721] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
18 Weinstein-Fudim L, Ergaz Z, Szyf M, Ornoy A. Prenatal S-Adenosine Methionine (SAMe) Induces Changes in Gene Expression in the Brain of Newborn Mice That Are Prevented by Co-Administration of Valproic Acid (VPA). Int J Mol Sci 2020;21:E2834. [PMID: 32325788 DOI: 10.3390/ijms21082834] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Huang G, Osorio D, Guan J, Ji G, Cai JJ. Overdispersed gene expression in schizophrenia. NPJ Schizophr 2020;6:9. [PMID: 32245959 DOI: 10.1038/s41537-020-0097-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
20 Zhao Y, Xiao W, Chen K, Zhan Q, Ye F, Tang X, Zhang X. Neurocognition and social cognition in remitted first-episode schizophrenia: correlation with VEGF serum levels. BMC Psychiatry 2019;19:403. [PMID: 31842818 DOI: 10.1186/s12888-019-2397-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Torun YT, Güney E, Aral A, Büyüktaşkin D, Tunca H, Taner YI, İşeri E. Determination of Serum Vascular Endothelial Growth Factor Levels in Attention Deficit Hyperactivity Disorder: A Case Control Study. Clin Psychopharmacol Neurosci 2019;17:517-22. [PMID: 31671489 DOI: 10.9758/cpn.2019.17.4.517] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
22 Zhang C, Ni P, Liu Y, Tian Y, Wei J, Xiang B, Zhao L, Li X, Ma X, Deng W, Guo W, Ni R, Zhang Y, Wang Q, Huang H, Zhang N, Li T. GABAergic Abnormalities Associated with Sensorimotor Cortico-striatal Community Structural Deficits in ErbB4 Knockout Mice and First-Episode Treatment-Naïve Patients with Schizophrenia. Neurosci Bull 2020;36:97-109. [PMID: 31388929 DOI: 10.1007/s12264-019-00416-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Kroken RA, Sommer IE, Steen VM, Dieset I, Johnsen E. Constructing the Immune Signature of Schizophrenia for Clinical Use and Research; An Integrative Review Translating Descriptives Into Diagnostics. Front Psychiatry. 2018;9:753. [PMID: 30766494 DOI: 10.3389/fpsyt.2018.00753] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 9.3] [Reference Citation Analysis]
24 Openshaw RL, Kwon J, McColl A, Penninger JM, Cavanagh J, Pratt JA, Morris BJ. JNK signalling mediates aspects of maternal immune activation: importance of maternal genotype in relation to schizophrenia risk. J Neuroinflammation 2019;16:18. [PMID: 30691477 DOI: 10.1186/s12974-019-1408-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
25 Lara E, Acurio J, Leon J, Penny J, Torres-Vergara P, Escudero C. Are the Cognitive Alterations Present in Children Born From Preeclamptic Pregnancies the Result of Impaired Angiogenesis? Focus on the Potential Role of the VEGF Family. Front Physiol 2018;9:1591. [PMID: 30487752 DOI: 10.3389/fphys.2018.01591] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
26 Lizano P, Lutz O, Ling G, Padmanabhan J, Tandon N, Sweeney J, Tamminga C, Pearlson G, Ruaño G, Kocherla M, Windemuth A, Clementz B, Gershon E, Keshavan M. VEGFA GENE variation influences hallucinations and frontotemporal morphology in psychotic disorders: a B-SNIP study. Transl Psychiatry 2018;8:215. [PMID: 30310054 DOI: 10.1038/s41398-018-0271-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
27 Kealy J, Greene C, Campbell M. Blood-brain barrier regulation in psychiatric disorders. Neurosci Lett 2020;726:133664. [PMID: 29966749 DOI: 10.1016/j.neulet.2018.06.033] [Cited by in Crossref: 54] [Cited by in F6Publishing: 58] [Article Influence: 13.5] [Reference Citation Analysis]
28 Horwitz T, Lam K, Chen Y, Xia Y, Liu C. A decade in psychiatric GWAS research. Mol Psychiatry 2019;24:378-89. [PMID: 29942042 DOI: 10.1038/s41380-018-0055-z] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 10.3] [Reference Citation Analysis]
29 Misiak B, Stramecki F, Stańczykiewicz B, Frydecka D, Lubeiro A. Vascular endothelial growth factor in patients with schizophrenia: A systematic review and meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 2018;86:24-9. [PMID: 29772306 DOI: 10.1016/j.pnpbp.2018.05.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
30 Frydecka D, Krzystek-Korpacka M, Lubeiro A, Stramecki F, Stańczykiewicz B, Beszłej JA, Piotrowski P, Kotowicz K, Szewczuk-Bogusławska M, Pawlak-Adamska E, Misiak B. Profiling inflammatory signatures of schizophrenia: A cross-sectional and meta-analysis study. Brain Behav Immun 2018;71:28-36. [PMID: 29730395 DOI: 10.1016/j.bbi.2018.05.002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 12.0] [Reference Citation Analysis]
31 Bocchio-chiavetto L, Zanardini R, Tosato S, Ventriglia M, Ferrari C, Bonetto C, Lasalvia A, Giubilini F, Fioritti A, Pileggi F, Pratelli M, Pavanati M, Favaro A, De Girolamo G, Frisoni GB, Ruggeri M, Gennarelli M. Immune and metabolic alterations in first episode psychosis (FEP) patients. Brain, Behavior, and Immunity 2018;70:315-24. [DOI: 10.1016/j.bbi.2018.03.013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
32 Xiao W, Zhan Q, Ye F, Tang X, Li J, Dong H, Sha W, Zhang X. Elevated serum vascular endothelial growth factor in treatment-resistant schizophrenia treated with electroconvulsive therapy: Positive association with therapeutic effects. World J Biol Psychiatry 2019;20:150-8. [PMID: 29611450 DOI: 10.1080/15622975.2018.1459048] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
33 Ye F, Zhan Q, Xiao W, Tang X, Li J, Dong H, Sha W, Zhang X. Altered serum levels of vascular endothelial growth factor in first-episode drug-naïve and chronic medicated schizophrenia. Psychiatry Res 2018;264:361-5. [PMID: 29677618 DOI: 10.1016/j.psychres.2018.04.027] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
34 Xiao W, Zhan Q, Ye F, Tang X, Li J, Dong H, Sha W, Zhang X. Baseline serum vascular endothelial growth factor levels predict treatment response to antipsychotic medication in patients with schizophrenia. Eur Neuropsychopharmacol 2018;28:603-9. [PMID: 29602597 DOI: 10.1016/j.euroneuro.2018.03.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
35 Krivoy A, Hochman E, Sendt K, Hollander S, Vilner Y, Selakovic M, Weizman A, Taler M. Association between serum levels of glutamate and neurotrophic factors and response to clozapine treatment. Schizophrenia Research 2018;192:226-31. [DOI: 10.1016/j.schres.2017.05.040] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
36 Howell KR, Armstrong J. Vascular Endothelial Growth Factor (VEGF) in Neurodevelopmental Disorders. Curr Behav Neurosci Rep 2017;4:299-308. [DOI: 10.1007/s40473-017-0130-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
37 Nguyen TT, Dev SI, Chen G, Liou SC, Martin AS, Irwin MR, Carroll JE, Tu X, Jeste DV, Eyler LT. Abnormal levels of vascular endothelial biomarkers in schizophrenia. Eur Arch Psychiatry Clin Neurosci 2018;268:849-60. [PMID: 28942562 DOI: 10.1007/s00406-017-0842-6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
38 Grissom NM, George R, Reyes TM. Suboptimal nutrition in early life affects the inflammatory gene expression profile and behavioral responses to stressors. Brain, Behavior, and Immunity 2017;63:115-26. [DOI: 10.1016/j.bbi.2016.10.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
39 Najjar S, Pahlajani S, De Sanctis V, Stern JNH, Najjar A, Chong D. Neurovascular Unit Dysfunction and Blood-Brain Barrier Hyperpermeability Contribute to Schizophrenia Neurobiology: A Theoretical Integration of Clinical and Experimental Evidence. Front Psychiatry 2017;8:83. [PMID: 28588507 DOI: 10.3389/fpsyt.2017.00083] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 13.6] [Reference Citation Analysis]
40 Katsel P, Roussos P, Pletnikov M, Haroutunian V. Microvascular anomaly conditions in psychiatric disease. Schizophrenia - angiogenesis connection. Neurosci Biobehav Rev 2017;77:327-39. [PMID: 28396239 DOI: 10.1016/j.neubiorev.2017.04.003] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
41 Zhang Y, Catts VS, Sheedy D, McCrossin T, Kril JJ, Shannon Weickert C. Cortical grey matter volume reduction in people with schizophrenia is associated with neuro-inflammation. Transl Psychiatry 2016;6:e982. [PMID: 27959331 DOI: 10.1038/tp.2016.238] [Cited by in Crossref: 69] [Cited by in F6Publishing: 62] [Article Influence: 11.5] [Reference Citation Analysis]
42 Lee SA, Huang KC. Epigenetic profiling of human brain differential DNA methylation networks in schizophrenia. BMC Med Genomics 2016;9:68. [PMID: 28117656 DOI: 10.1186/s12920-016-0229-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
43 Lizano PL, Yao JK, Tandon N, Mothi SS, Montrose DM, Keshavan MS. Association of sFlt-1 and worsening psychopathology in relatives at high risk for psychosis: A longitudinal study. Schizophr Res 2017;183:75-81. [PMID: 27863935 DOI: 10.1016/j.schres.2016.11.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
44 Hino M, Kunii Y, Matsumoto J, Wada A, Nagaoka A, Niwa S, Takahashi H, Kakita A, Akatsu H, Hashizume Y, Yamamoto S, Yabe H. Decreased VEGFR2 expression and increased phosphorylated Akt1 in the prefrontal cortex of individuals with schizophrenia. J Psychiatr Res 2016;82:100-8. [PMID: 27484635 DOI: 10.1016/j.jpsychires.2016.07.018] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
45 Koido K, Innos J, Haring L, Zilmer M, Ottas A, Vasar E. Taurine and Epidermal Growth Factor Belong to the Signature of First-Episode Psychosis. Front Neurosci 2016;10:331. [PMID: 27471446 DOI: 10.3389/fnins.2016.00331] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
46 Smagula SF, Lotrich FE, Aizenstein HJ, Diniz BS, Krystek J, Wu GF, Mulsant BH, Butters MA, Reynolds CF 3rd, Lenze EJ. Immunological biomarkers associated with brain structure and executive function in late-life depression: exploratory pilot study. Int J Geriatr Psychiatry 2017;32:692-9. [PMID: 27282141 DOI: 10.1002/gps.4512] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
47 Lizano PL, Keshavan MS, Tandon N, Mathew IT, Mothi SS, Montrose DM, Yao JK. Angiogenic and immune signatures in plasma of young relatives at familial high-risk for psychosis and first-episode patients: A preliminary study. Schizophr Res 2016;170:115-22. [PMID: 26692348 DOI: 10.1016/j.schres.2015.12.001] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]